By William Gullotti
Buffalo, N.Y., June 27 – JPMorgan Chase Financial Co. LLC priced $4.4 million of 0% capped enhanced participation equity notes due Dec. 27, 2023 linked to the SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.
The notes are guaranteed by JPMorgan Chase & Co.
If the ETF return greater than the initial level, the payout at maturity will be par plus 300% of the ETF return, subject to a maximum settlement amount of par plus 53.55%.
Investors will be fully exposed to any ETF decline.
J.P. Morgan Securities LLC is the agent.
| Issuer: | JPMorgan Chase Financial Co. LLC
|
| Guarantor: | JPMorgan Chase & Co.
|
| Issue: | Capped enhanced participation equity notes
|
| Underlying ETF: | SPDR S&P Biotech ETF
|
| Amount: | $4.4 million
|
| Maturity: | Dec. 27, 2023
|
| Coupon: | 0%
|
| Price: | Par
|
| Payout at maturity: | If ETF gains, par plus 300% of the gain, capped at par plus 53.55%; otherwise, full exposure to loss
|
| Initial level: | $71.79
|
| Pricing date: | June 22
|
| Settlement date: | June 29
|
| Agent: | J.P. Morgan Securities LLC
|
| Fees: | 1.51%
|
| Cusip: | 48133G7B3
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
